nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
L-3 Actions of drugs used against mood disorders on second messenger systems: A focus on the cAMP signaling system
|
Mørk, A. |
|
1996 |
6 |
S1 |
p. S1-S2 2 p. |
artikel |
2 |
L-101 Acute and long term treatment — How long do you need to treat depression?
|
Montgomery, Stuart A. |
|
1996 |
6 |
S1 |
p. S6-S7 2 p. |
artikel |
3 |
L-15 Atypical and subclinical forms of bipolarity
|
Cassano, G.B. |
|
1996 |
6 |
S1 |
p. S9- 1 p. |
artikel |
4 |
L-11 Clinical Efficacy of Antidepressants in Unipolar Depression
|
Paykel, E.S. |
|
1996 |
6 |
S1 |
p. S7-S8 2 p. |
artikel |
5 |
L-2 Comparison of the clinical and pharmacological efficacy of the presently available drugs for mood disorders
|
Leonard, B. |
|
1996 |
6 |
S1 |
p. S10- 1 p. |
artikel |
6 |
L-7 CRH in affective disorders
|
Holsboer-Trachsler, E. |
|
1996 |
6 |
S1 |
p. S4- 1 p. |
artikel |
7 |
L-5 Critical progress in MAO inhibition in the treatment of mood disorders
|
Vetulani, J. |
|
1996 |
6 |
S1 |
p. S3- 1 p. |
artikel |
8 |
L-18 Depression, antidepressant drug treatment and cognitive impairment in old age
|
Gottfries, C.G. |
|
1996 |
6 |
S1 |
p. S9-S10 2 p. |
artikel |
9 |
L-4 Focusing on serotonin for the action of drugs effective in mood disorders: pre-synaptic versus postsynaptic mechanisms
|
Nutt, D.J. |
|
1996 |
6 |
S1 |
p. S2-S3 2 p. |
artikel |
10 |
L-1 Historical perspectives and current problems in the classification, diagnosis and treatment of mood disorders: New clinical specifiers
|
Angst, J. |
|
1996 |
6 |
S1 |
p. S1- 1 p. |
artikel |
11 |
L-6 Neuropeptides: Targets for antidepressants?
|
van Ree, J.M. |
|
1996 |
6 |
S1 |
p. S3-S4 2 p. |
artikel |
12 |
L-13 New strategies in the management of refractory depression
|
Dinan, T.G. |
|
1996 |
6 |
S1 |
p. S8-S9 2 p. |
artikel |
13 |
L-16 Predictors of course and treatment response in bipolar affective disorder
|
Scott, Jan |
|
1996 |
6 |
S1 |
p. S9- 1 p. |
artikel |
14 |
L-9 Psychoimmunological aspects of mood disorders
|
Ackenheil, M. |
|
1996 |
6 |
S1 |
p. S6- 1 p. |
artikel |
15 |
L-8 Stressor-susceptibility, cortisol-hypersecretion, and serotonin deficiency. The major determinants of a hypothetical subtype of depression
|
van Praag, H.M. |
|
1996 |
6 |
S1 |
p. S5-S6 2 p. |
artikel |
16 |
P-61 Acetylcholine mediateds the effects of serotonin on hippocampal excitability in the intact rat brain
|
Levkovitz, Y. |
|
1996 |
6 |
S1 |
p. S31-S32 2 p. |
artikel |
17 |
P-44 A comparison fluvoxamine and cognitive-behaviour therapy in treatment of obsessive-compulsive disorder (OCD)
|
Sungur, M.Z. |
|
1996 |
6 |
S1 |
p. S25- 1 p. |
artikel |
18 |
P-7 Affective disorders are accompanied by cerebral asymmetry changes
|
Egorov, Alexel Y. |
|
1996 |
6 |
S1 |
p. S13- 1 p. |
artikel |
19 |
P-60 Alteration of cholinergic pressor response in AF64A-induced Alzheimer model in rats
|
Tellioglu, T. |
|
1996 |
6 |
S1 |
p. S31- 1 p. |
artikel |
20 |
P-15 Ambulatory eeg and sleep study in 194 treated depressed patients
|
Lesnicki, N. |
|
1996 |
6 |
S1 |
p. S15- 1 p. |
artikel |
21 |
P-57 Analgesic effects of intrathecal administration of calcium channel blockers in mice
|
Dogrul, A. |
|
1996 |
6 |
S1 |
p. S30- 1 p. |
artikel |
22 |
P-41 Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors
|
Przegaliński, E. |
|
1996 |
6 |
S1 |
p. S24- 1 p. |
artikel |
23 |
P-36 Antidepressant choice in the outpatient department of a psychiatry clinic
|
Işelli, I. |
|
1996 |
6 |
S1 |
p. S22- 1 p. |
artikel |
24 |
P-40 Antipanic properties of the selective 5HT2c receptor agonist Ro 60-0332 and partial agonist Ro 60-0017 in a novel model of panic-like anxiety in rats
|
Jenck, F. |
|
1996 |
6 |
S1 |
p. S24- 1 p. |
artikel |
25 |
P-69 Assistance of EEG in the diagnosis and treatment of anxiety disorders
|
Taneli, B. |
|
1996 |
6 |
S1 |
p. S34-S35 2 p. |
artikel |
26 |
P-21 Augmentation of antidepressant response by lithium — changes in acute phase proteins
|
Sluzewska, A. |
|
1996 |
6 |
S1 |
p. S17- 1 p. |
artikel |
27 |
P-4 Behavioral effects of acute and chronic Moclobemide administrations in mice
|
Akarsu, E.S. |
|
1996 |
6 |
S1 |
p. S12- 1 p. |
artikel |
28 |
P-1 Behavioural and in vivo microdialysis studies on rats after selective chemical denervation of the locus coeruleus projections: implications for the theory of depression
|
Harro, J. |
|
1996 |
6 |
S1 |
p. S11- 1 p. |
artikel |
29 |
P-10 Blunted thyroid stimulating hormone and unaltered growth hormone responses to thyrothropine releasing hormone in major depression
|
Eryllmaz, M.M. |
|
1996 |
6 |
S1 |
p. S14- 1 p. |
artikel |
30 |
P-33 Can antidepressants prevent institutional care? Citalopram in the treatment of elderly depressed patients with and without dementia disorders
|
Koskinen, T. |
|
1996 |
6 |
S1 |
p. S21-S22 2 p. |
artikel |
31 |
P-13 Cholesterol and suicidality in major depression: a pilot study
|
Dannon, P.N. |
|
1996 |
6 |
S1 |
p. S14-S15 2 p. |
artikel |
32 |
P-30 Clopixol Acuphase® in the treatment of mania in a hospital setting
|
Stefanov, S. |
|
1996 |
6 |
S1 |
p. S20- 1 p. |
artikel |
33 |
P-28 Comparison of moclobemide and sertraline in the treatment of atypical depression: A preliminary study
|
Örsel, S.D. |
|
1996 |
6 |
S1 |
p. S19-S20 2 p. |
artikel |
34 |
P-16 Depression and altered immunity: Clinical implications for immunologic processes
|
Stankovska, G. |
|
1996 |
6 |
S1 |
p. S15- 1 p. |
artikel |
35 |
P-6 Depression and schizophrenia: brain stem auditory evoked potentials
|
Kimhi, R. |
|
1996 |
6 |
S1 |
p. S13- 1 p. |
artikel |
36 |
P-14 Early P300 and late P300 in 415 treated patients suffering from a depressive syndrome
|
Debatisse, D. |
|
1996 |
6 |
S1 |
p. S15- 1 p. |
artikel |
37 |
P-53 Effects of acute administration of clozapine on local cerebral glucose utilization in the rat
|
Colangelo, V. |
|
1996 |
6 |
S1 |
p. S28-S29 2 p. |
artikel |
38 |
P-59 Effects of dexfenfluramine on glucose-conditioned flavour preference in rats
|
Şenöz, S. |
|
1996 |
6 |
S1 |
p. S30-S31 2 p. |
artikel |
39 |
P-2 Effects of electroconvulsive seizures on protein kinase C-induced potentiation of cyclic AMP response are modified by pretreatment with antidepressant drugs
|
Nalepa, I. |
|
1996 |
6 |
S1 |
p. S11- 1 p. |
artikel |
40 |
P-51 Effects of L-Arginine on behavioural symptoms of ethanol withdrawal syndrome in rats
|
Uzbay, I.T. |
|
1996 |
6 |
S1 |
p. S27-S28 2 p. |
artikel |
41 |
P-12 Effects of Lithium treatment on thyroid functions in remitted bipolar patients
|
Gönül, A.S. |
|
1996 |
6 |
S1 |
p. S14- 1 p. |
artikel |
42 |
P-45 Efficacy and safety of Paroxetine in Panic Disorder
|
Judge, R. |
|
1996 |
6 |
S1 |
p. S25-S26 2 p. |
artikel |
43 |
P-25 Efficacy and safety of sertraline in major depression
|
Çetin, M. |
|
1996 |
6 |
S1 |
p. S18-S19 2 p. |
artikel |
44 |
P-49 Flumazenil exhibits a diazepam like-effect in Electroconvulsive shock-treated rats
|
Çelik, Turgay |
|
1996 |
6 |
S1 |
p. S27- 1 p. |
artikel |
45 |
P-29 Fluoxetine versus moclobemide in elderly depressed patients
|
Bugarski-Kirola, D. |
|
1996 |
6 |
S1 |
p. S20- 1 p. |
artikel |
46 |
P-31 Four-year outcomes for maintenance therapies in unipolar subjects with high probability of recurrence
|
Zanardi, R. |
|
1996 |
6 |
S1 |
p. S20-S21 2 p. |
artikel |
47 |
P-63 Glycine influence on white blood cells fermental status and psychological sights of teenagers with defiant behavior
|
Ternovskaya, V.A. |
|
1996 |
6 |
S1 |
p. S32- 1 p. |
artikel |
48 |
P-20 Lithium pharmacokinetics and treatment of mood disorders
|
Gorkov, V.A. |
|
1996 |
6 |
S1 |
p. S16-S17 2 p. |
artikel |
49 |
P-54 L-NAME inhibits pentylenetetrazole and strychnine induced seizures in mice
|
Kaputlu, I. |
|
1996 |
6 |
S1 |
p. S29- 1 p. |
artikel |
50 |
P-34 Memory improving activity of fluoxetine in humans and rats
|
Nowakowska, E. |
|
1996 |
6 |
S1 |
p. S22- 1 p. |
artikel |
51 |
P-24 Milnacipran: A double and well-balanced noradrenaline and serotonin reuptake inhibitor: Results of comparative clinical trials
|
Tournoux, A. |
|
1996 |
6 |
S1 |
p. S18- 1 p. |
artikel |
52 |
P-5 Milnacipran, a new well-balanced double noradrenaline and serotonin reuptake inhibitor: Biochemical and pharmacological characteristics.
|
Briley, M. |
|
1996 |
6 |
S1 |
p. S12- 1 p. |
artikel |
53 |
P-11 Minimal electrocardiographic anomalies in patients treated with tricyclic antidepressants
|
Mungo, S. |
|
1996 |
6 |
S1 |
p. S14- 1 p. |
artikel |
54 |
P-27 Moclobemide and sertraline in the treatment of melancholic depression: a comparative study
|
Türkşapar, M.H. |
|
1996 |
6 |
S1 |
p. S19- 1 p. |
artikel |
55 |
P-22 Nifedipine steady-state pharmacokinetics in prophylactic treatment of mood disorders
|
Rozova, G.I. |
|
1996 |
6 |
S1 |
p. S17- 1 p. |
artikel |
56 |
P-8 Observations on depression during adolescence
|
Berti, A. |
|
1996 |
6 |
S1 |
p. S13- 1 p. |
artikel |
57 |
P-46 Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: A double blind study
|
Judge, R. |
|
1996 |
6 |
S1 |
p. S26- 1 p. |
artikel |
58 |
P-18 Pharmacokinetic markers of psychotropic drug response
|
Rozov, A.K. |
|
1996 |
6 |
S1 |
p. S16- 1 p. |
artikel |
59 |
P-23 Pharmacokinetic-pharmacadynamic relationship of milnacipran on platelet uptake model
|
Puozzoa, C. |
|
1996 |
6 |
S1 |
p. S17-S18 2 p. |
artikel |
60 |
P-66 Platelet guanine nucleotide-binding protein and antidepressant drugs treatment in major depressed patients
|
Karege, F. |
|
1996 |
6 |
S1 |
p. S33-S34 2 p. |
artikel |
61 |
P-65 Platelets MAO in relation to alcohol abuse, suicidal or aggressive behavior among voluntarily admitted psychiatric patients
|
Wistedt, B |
|
1996 |
6 |
S1 |
p. S33- 1 p. |
artikel |
62 |
P-3 Pramipexole, a selective dopamine receptor agonist with potential antidepressant activity
|
Maj, J. |
|
1996 |
6 |
S1 |
p. S11-S12 2 p. |
artikel |
63 |
P-38 Psychopharmacotherapy of comorbid mood disorders and pain syndromes
|
Doksat, M.K. |
|
1996 |
6 |
S1 |
p. S23- 1 p. |
artikel |
64 |
P-43 Reversible MAO-A inhibitors in the treatment of panic disorder
|
Georgiev, S. |
|
1996 |
6 |
S1 |
p. S25- 1 p. |
artikel |
65 |
P-67 Search for possible molecular defects in the platelet serotonin (5-HT) carrier in patients with treatment-refractory endogenous depression
|
Lozier, R.H. |
|
1996 |
6 |
S1 |
p. S34- 1 p. |
artikel |
66 |
P-62 State of the mood and coping strategies in relation to the physical activity and fitness
|
Salloa, M. |
|
1996 |
6 |
S1 |
p. S32- 1 p. |
artikel |
67 |
P-48 The action of kavain, a kava pyrone prepared from the psychotropic remedy Piper methysticum, on presynaptic neurotransmission
|
Gleitz, J. |
|
1996 |
6 |
S1 |
p. S26-S27 2 p. |
artikel |
68 |
P-58 The analgesic effect of amlodipine and its interaction with morphine, ketorolac and naloxone after peripheral and central administration in mice
|
Dogrul, A. |
|
1996 |
6 |
S1 |
p. S30- 1 p. |
artikel |
69 |
P-56 The counteracting effects of bromocriptine on locomotor activity and its interaction with amlodipine
|
Dogrul, A. |
|
1996 |
6 |
S1 |
p. S29-S30 2 p. |
artikel |
70 |
P-68 The dexamethasone suppression test and thyroid releasing hormone test in major depression
|
Bilici, M. |
|
1996 |
6 |
S1 |
p. S34- 1 p. |
artikel |
71 |
P-19 The drug effects pharmacokinetic determinants as a basis for optimal psychotropic drug dosage form prediction
|
Karamisheva, E.I. |
|
1996 |
6 |
S1 |
p. S16- 1 p. |
artikel |
72 |
P-47 The effects of amitriptyline and clomipramine on learning and memory in an elevated plus-maze test in mice
|
Nurten, A. |
|
1996 |
6 |
S1 |
p. S26- 1 p. |
artikel |
73 |
P-55 The effects of amlodipine and verapamil after peripheral and central administration against pentylenetetrazole convulsions
|
Dogrul, A. |
|
1996 |
6 |
S1 |
p. S29- 1 p. |
artikel |
74 |
P-50 The effects of flumazenil on two-way active avoidance, in diazepam-treated rats
|
Çelik, Turgay |
|
1996 |
6 |
S1 |
p. S27- 1 p. |
artikel |
75 |
P-17 The effects of interaction between the cholinergic and serotonergic systems on the cognitive impairment in depression and ECT
|
Levkovitz, Y. |
|
1996 |
6 |
S1 |
p. S15-S16 2 p. |
artikel |
76 |
P-26 The efficacy and safety of sertraline in major depression
|
Gülseren, Ş. |
|
1996 |
6 |
S1 |
p. S19- 1 p. |
artikel |
77 |
P-35 The efficacy of cisapride in managing nausea produced by selective serotonin reuptake inhibitors: a placebo controlled study
|
Kara, H. |
|
1996 |
6 |
S1 |
p. S22- 1 p. |
artikel |
78 |
P-52 The importance of voltage-dependent calcium channel in withdrawal effects after chronic treatment with haloperidol
|
Michaluk, J.T. |
|
1996 |
6 |
S1 |
p. S28- 1 p. |
artikel |
79 |
P-37 Therapeutic consequences of inpatients' comorbidity and multimorbidity
|
Molnár, Gy. |
|
1996 |
6 |
S1 |
p. S23- 1 p. |
artikel |
80 |
P-32 The safeness of labetalol in electroconvulsive therapy
|
Dannon, P.N. |
|
1996 |
6 |
S1 |
p. S21- 1 p. |
artikel |
81 |
P-42 The treatment of acute Posttraumatic Stress Disorder with Fluoxetine
|
Folnegović-Šmalcv, V. |
|
1996 |
6 |
S1 |
p. S24-S25 2 p. |
artikel |
82 |
P-39 Training course for primary care physicians and medical students in the management of depression
|
Alkin, T. |
|
1996 |
6 |
S1 |
p. S23-S24 2 p. |
artikel |
83 |
P-9 Variations in lymphocyte subsets in major depressive disorder
|
Özcan, E. |
|
1996 |
6 |
S1 |
p. S13- 1 p. |
artikel |
84 |
P-64 Working out the system of health protection for persons of intellectual labor
|
Ternovskaya, V.A. |
|
1996 |
6 |
S1 |
p. S32-S33 2 p. |
artikel |